Related Experiment Video
Updated: Jun 9, 2026
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Protein Carbonylation as a Biomarker of Oxidative Stress and a Therapeutic Target in Neonatal Brain Damage
José Martínez-Orgado1,2, María Martínez-Vega1, Laura Silva1
1Biomedical Research Foundation, Hospital Clínico San Carlos-IdISSC, 28040 Madrid, Spain.
Insights
Oxidative stress harms the developing brain, particularly oligodendrocytes, leading to myelination issues. Protein carbonylation is a key marker and therapeutic target in neonatal brain injury, with antioxidants like cannabidiol showing neuroprotection.
Area of Science:
- Neuroscience
- Biochemistry
- Developmental Biology
Background:
- Oxidative stress (OS) is a major cause of brain damage, especially in the immature brain due to vulnerable oligodendrocytes.
- OS can lead to long-term myelination impairment in neonates.
- Protein carbonylation is a significant marker of OS-induced damage in various neonatal brain injury models.
Purpose of the Study:
- To investigate the role of protein carbonylation in neonatal brain injury.
- To explore protein carbonylation as a therapeutic target for mitigating neonatal brain damage.
- To assess the neuroprotective effects of antioxidants, such as cannabidiol, on protein carbonylation and brain injury.
Main Methods:
- Analysis of protein carbonylation levels in diverse animal models of neonatal brain injury (hypoxic-ischemic insults, intraventricular hemorrhage).
- Evaluation of the impact of protein carbonylation on cell injury and inflammation.
- Administration of cannabidiol (antioxidant) to assess its effects on cerebral damage, neurobehavior, and myelination.
Main Results:
- Elevated protein carbonylation was observed across various neonatal brain injury models and species.
- Protein carbonylation contributes to cell injury and inflammation amplification in the immature brain.
- Cannabidiol administration reduced cerebral damage, improved neurobehavioral performance, and preserved myelination, linked to protein carbonylation modulation.
Conclusions:
- Protein carbonylation is a critical indicator and contributor to neonatal brain injury.
- Targeting protein carbonylation with antioxidants like cannabidiol offers significant neuroprotection.
- Assessing protein carbonylation is valuable for understanding neonatal brain injury mechanisms and therapeutic strategies.
Abstract:
Oxidative stress (OS) constitutes a pivotal factor within the mechanisms underlying brain damage, for which the immature brain is particularly vulnerable. This vulnerability is caused by the abundance of immature oligodendrocytes in the immature brain, which are highly susceptible to OS-induced harm. Consequently, any injurious process involving OS within the immature brain can lead to long-term myelination impairment. Among the detrimental repercussions of OS, protein carbonylation stands out as a prominently deleterious consequence. Noteworthy elevation of protein carbonylation is observable across diverse models of neonatal brain injury, following both diffuse and focal hypoxic-ischemic insults, as well as intraventricular hemorrhage, in diverse animal species encompassing rodents and larger mammals, and at varying stages of brain development. In the immature brain, protein carbonylation manifests as a byproduct of reactive nitrogen species, bearing profound implications for cell injury, particularly in terms of inflammation amplification. Moreover, protein carbonylation appears as a therapeutic target for mitigating neonatal brain damage. The administration of a potent antioxidant, such as cannabidiol, yields substantial neuroprotective effects. These encompass the reduction in cerebral damage, restoration of neurobehavioral performance, and preservation of physiological myelination. Such effects are linked to the modulation of protein carbonylation. The assessment of protein carbonylation emerges as a reliable method for comprehending the intricate mechanisms underpinning damage and neuroprotection within neonatal brain injury.
